Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | ABAT | P80404 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3925426 | 0.98 | SLC6A2 (0.47) | TAAR1SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL1661396 | 0.84 | EPHX1 (0.45) | TAAR1SLC6A2SLC6A4SLC6A3SLC7A5 | |
| SCHEMBL1152681 | 0.84 | EPHX1 (0.45) | TAAR1SLC6A2SLC6A4SLC6A3SLC7A5 | |
| SCHEMBL1153151 | 0.82 | EPHX1 (0.47) | TAAR1SLC6A2SLC6A4SLC6A3SLC7A5 | |
| SCHEMBL1661394 | 0.82 | EPHX1 (0.47) | TAAR1SLC6A2SLC6A4SLC6A3SLC7A5 | |
| SCHEMBL4407969 | 0.81 | SLC6A4 (0.51) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1153125 | 0.79 | EPHX1 (0.47) | TAAR1SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL1870612 | 0.76 | SLC6A2 (0.52) | TAAR1SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL3414882 | 0.76 | SLC6A2 (0.46) | TAAR1SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL4665051 | 0.76 | SLC6A2 (0.52) | TAAR1SLC6A2SLC6A4OPRM1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2061750-A2 | IMPROVED PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF | Medichem, S.A. (ES) | 2009-05-27 | — | — | EP | claimed |
| WO-2008015584-A2 | IMPROVED PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF | MEDICHEM, S.A. (US) | 2008-02-07 | — | — | WO | claimed |
| WO-2009073066-A1 | PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-06-11 | — | — | WO | disclosed |
| EP-2061750-A2 | IMPROVED PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF | Medichem, S.A. (ES) | 2009-05-27 | — | — | EP | disclosed |
| EP-2035366-A1 | PROCESS FOR PREPARATION OF 0-DESMETHYLVENLAFAXINE AND ITS ANALOGUES | KRKA (SI) | 2009-03-18 | — | — | EP | disclosed |
| EP-1934168-A2 | TRIDESMETHYLVENLAFAXINE AND PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | Teva Pharmaceutical Industries Ltd (IL) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008015584-A2 | IMPROVED PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF | MEDICHEM, S.A. (US) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008013995-A2 | TRIDESMETHYLVENLAFAXINE AND PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-01-31 | — | — | WO | disclosed |
| WO-2007147564-A1 | PROCESS FOR PREPARATION OF 0-DESMETHYLVENLAFAXINE AND ITS ANALOGUES | KRKA (SI) | 2007-12-27 | — | — | WO | disclosed |